Low-Molecular-Weight Fucoidan Inhibits Thromboinflammation and Ameliorates Deep Vein Thrombosis via Targeting S100A8/A9
Marine Drugs · 2025
DOI: 10.3390/md23050180 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, 2025. Verfasst von Yiting Feng und 12 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Marine Drugs, School of Medicine and Pharmacy, Ocean University of China, Chinese Ministry of Education, Qingdao 266000, China. Hauptthemen laut MEDLINE: Polysaccharides, Calgranulin B, Calgranulin A, Venous Thrombosis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Excellent Young Scholars of the Natural Science Foundation of Shandong Province, Young experts of Taishan Scholars, Qingdao Postdoctoral Program.
Themen: Thromboseprophylaxe
Abstract (Originalsprache)
Deep vein thrombosis (DVT) is a prevalent life-threatening complication among hospitalized patients. DVT is characterized by the hypercoagulability and thromboinflammation in which platelet activation and neutrophil extracellular trap (NET) formation are critically involved. Studies have shown that S100A8/A9 is significantly elevated in patients with DVT, and is closely associated with platelet activation and NET formation. Fucoidan, the marine polysaccharide derived from Fucus algae, has potential anti-inflammatory and cardioprotective effects. We found low-molecular-weight fucoidan (LMF) bound to S100A8/A9 with an equilibrium dissociation constant (KD) of 2.368 × 10−8 M. LMF inhibited S100A8/A9-induced platelet hyperactivity and NET formation in vitro, and ameliorated DVT without significantly perturbing hemostasis in vivo. Our results indicate that the alarmin protein S100A8/A9 is a novel target of LMF. LMF may have therapeutic potential in S100A8/A9-induced thromboinflammation in DVT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Marine Drugs, School of Medicine and Pharmacy, Ocean University of China, Chinese Ministry of Education, Qingdao 266000, China.
- Laboratory for Marine Drugs and Bioproducts, Qingdao Marine Science and Technology Center, Qingdao 266071, China.
- Shandong Provincial Key Laboratory of Glycoscience and Glycotechnology, Qingdao 266000, China.
ORCID-Profile: Weiqing Zhao, Chao Cai, Chuanbin Shen
Förderung
- Excellent Young Scholars of the Natural Science Foundation of Shandong Province
- Young experts of Taishan Scholars
- Qingdao Postdoctoral Program
- Key Laboratory of Cardiovascular Disease of Yunnan Province
- Fundamental Research Funds for the Central Universities
- Youth Talents Project of Ocean University of China
- Laboratory for Marine Drugs and Bioproducts, Qingdao Marine Science and Technology Center (CS)
Zitieren
APA
Feng, Y., Zhao, W., Fang, S., Zhao, J., Wang, W., Zhou, S., Wang, T., Fang, X., Chen, X., Awais, M., Cai, C., Shen, C., & Liu, M. (2025). Low-Molecular-Weight Fucoidan Inhibits Thromboinflammation and Ameliorates Deep Vein Thrombosis via Targeting S100A8/A9. Marine Drugs. https://doi.org/10.3390/md23050180
Vancouver
Feng Y, Zhao W, Fang S, Zhao J, Wang W, Zhou S, et al. Low-Molecular-Weight Fucoidan Inhibits Thromboinflammation and Ameliorates Deep Vein Thrombosis via Targeting S100A8/A9. Marine Drugs. 2025. doi:10.3390/md23050180
BibTeX
@article{Feng2025,
author = {Feng, Yiting and Zhao, Weiqing and Fang, Siwen and Zhao, Jingwen and Wang, Wanshuai and Zhou, Shaoyun and Wang, Tianyu and Fang, Xinke and Chen, Xue and Awais, Muhammad and Cai, Chao and Shen, Chuanbin and Liu, Ming},
title = {Low-Molecular-Weight Fucoidan Inhibits Thromboinflammation and Ameliorates Deep Vein Thrombosis via Targeting S100A8/A9},
journal = {Marine Drugs},
year = {2025},
doi = {10.3390/md23050180}
}
EUVIMED